These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2914623)
1. Dimethyl sulfoxide modulation of diabetes onset in NOD mice. Klandorf H; Chirra AR; DeGruccio A; Girman DJ Diabetes; 1989 Feb; 38(2):194-7. PubMed ID: 2914623 [TBL] [Abstract][Full Text] [Related]
2. Dimethyl sulfoxide inhibits spontaneous diabetes and autoimmune recurrence in non-obese diabetic mice by inducing differentiation of regulatory T cells. Lin GJ; Sytwu HK; Yu JC; Chen YW; Kuo YL; Yu CC; Chang HM; Chan DC; Huang SH Toxicol Appl Pharmacol; 2015 Jan; 282(2):207-14. PubMed ID: 25481496 [TBL] [Abstract][Full Text] [Related]
3. Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis. Brien S; Prescott P; Bashir N; Lewith H; Lewith G Osteoarthritis Cartilage; 2008 Nov; 16(11):1277-88. PubMed ID: 18417375 [TBL] [Abstract][Full Text] [Related]
4. The prevention of alloxan-induced diabetes in mice by dimethyl sulfoxide. Heikkila RE Eur J Pharmacol; 1977 Jul; 44(2):191-3. PubMed ID: 885168 [TBL] [Abstract][Full Text] [Related]
5. Predisposing effect of anti-beta cell autoimmune process in NOD mice on the induction of diabetes by environmental insults. Ihm SH; Lee KU; McArthur RG; Yoon JW Diabetologia; 1990 Dec; 33(12):709-12. PubMed ID: 2150051 [TBL] [Abstract][Full Text] [Related]
6. High-fructose diet preserves beta-cell mass and prevents diabetes in nonobese diabetic mice: A potential role for increased insulin receptor substrate-2 expression. Orban T; Landaker E; Ruan Z; Cordeman TP; Weitgasser R; Bonner-Weir S; Jackson RA; Patti ME Metabolism; 2001 Nov; 50(11):1369-76. PubMed ID: 11699059 [TBL] [Abstract][Full Text] [Related]
7. The NOD mouse as a model of type I diabetes. Tochino Y Crit Rev Immunol; 1987; 8(1):49-81. PubMed ID: 2961513 [TBL] [Abstract][Full Text] [Related]
8. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Wicker LS; Miller BJ; Mullen Y Diabetes; 1986 Aug; 35(8):855-60. PubMed ID: 3525284 [TBL] [Abstract][Full Text] [Related]
10. Methylsulfonylmethane (MSM), an organosulfur compound, is effective against obesity-induced metabolic disorders in mice. Sousa-Lima I; Park SY; Chung M; Jung HJ; Kang MC; Gaspar JM; Seo JA; Macedo MP; Park KS; Mantzoros C; Lee SH; Kim YB Metabolism; 2016 Oct; 65(10):1508-21. PubMed ID: 27621186 [TBL] [Abstract][Full Text] [Related]
11. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Yasunami R; Bach JF Eur J Immunol; 1988 Mar; 18(3):481-4. PubMed ID: 2965652 [TBL] [Abstract][Full Text] [Related]
12. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes. Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873 [TBL] [Abstract][Full Text] [Related]
13. CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice. Yoneda R; Yokono K; Nagata M; Tominaga Y; Moriyama H; Tsukamoto K; Miki M; Okamoto N; Yasuda H; Amano K; Kasuga M Diabetologia; 1997 Sep; 40(9):1044-52. PubMed ID: 9300241 [TBL] [Abstract][Full Text] [Related]
14. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Jacob CO; Aiso S; Michie SA; McDevitt HO; Acha-Orbea H Proc Natl Acad Sci U S A; 1990 Feb; 87(3):968-72. PubMed ID: 2405400 [TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Charlton B; Bacelj A; Slattery RM; Mandel TE Diabetes; 1989 Apr; 38(4):441-7. PubMed ID: 2522407 [TBL] [Abstract][Full Text] [Related]
16. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Elias D; Markovits D; Reshef T; van der Zee R; Cohen IR Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1576-80. PubMed ID: 2406723 [TBL] [Abstract][Full Text] [Related]
17. Preventive effects of andrographolide on the development of diabetes in autoimmune diabetic NOD mice by inducing immune tolerance. Zhang C; Gui L; Xu Y; Wu T; Liu D Int Immunopharmacol; 2013 Aug; 16(4):451-6. PubMed ID: 23707775 [TBL] [Abstract][Full Text] [Related]
18. Involvement of O2 radicals in 'autoimmune' diabetes. Nomikos IN; Wang Y; Lafferty KJ Immunol Cell Biol; 1989 Feb; 67 ( Pt 1)():85-7. PubMed ID: 2542156 [TBL] [Abstract][Full Text] [Related]
19. Reduction of diabetes incidence in NOD mice by neonatal glucose treatment. Bock T; Kjaer TW; Jørgensen M; Josefsen K; Rygaard J; Buschard K APMIS; 1991 Nov; 99(11):989-92. PubMed ID: 1958355 [TBL] [Abstract][Full Text] [Related]
20. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus. Hermitte L; Vialettes B; Naquet P; Atlan C; Payan MJ; Vague P Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]